Appointment
Are you interested in our service? Book an appointment today.
Working Hour
- 8:00 - 18:00
- 8:00 - 18:00
- 8:00 - 18:00
- 8:00 - 18:00
- 8:00 - 18:00
- 8:00 - 18:00
- 8:00 - 18:00
Oncology
Cancer is a complex and multifaceted disease. At Oncogenomics, we are at the forefront of oncology genetic testing, analyzing the genetic mutations that can lead to the development and progression of various cancers. With our state-of-the-art technology and unparalleled expertise, we empower patients and healthcare providers with actionable insights, paving the way for personalized treatments and better outcomes.
Targeted Gene Panels
We run panels that target specific genes or regions known to harbor cancer-associated mutations. For instance, gene panels that target actionable mutations in lung cancer, melanoma, or colorectal cancer can help inform targeted therapies.
Tumor Profiling
Comprehensive genomic profiling of tumors to detect mutations, insertions, deletions, or copy number variations that might be driving the cancer.
Liquid Biopsies
Analyzing circulating tumor DNA (ctDNA) in the bloodstream to detect cancer-related mutations, which can be useful for monitoring disease progression, detecting minimal residual disease, or tracking response to treatment.
Tumor Mutation Burden (TMB)
Measuring the number of mutations in tumor cells can provide insights into the likelihood of the cancer responding to immunotherapies.
Microsatellite Instability (MSI) Analysis
MSI is a condition that indicates defects in DNA mismatch repair. Cancers with high MSI (MSI-H) might respond well to certain immunotherapies.
Pharmacogenomics
Understanding how genetic variations might affect a patient’s response to specific cancer drugs.
Leukemia and Lymphoma Subtyping
Detecting specific genetic rearrangements or mutations that can classify subtypes of leukemia or lymphoma, which can guide treatment decisions.
Fusion Gene Detection
Identifying fusion genes that result from chromosomal rearrangements and might drive certain cancers.
Clonality Analysis
In hematologic malignancies, understanding the clonal architecture of the disease can offer insights into its progression and potential treatment strategies.
